Wealthcare Advisory Partners’s Evolus EOLS Stock Holding History

Wealthcare Advisory Partners’s Portfolio EOLS Stock Details EOLS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-100	Closed	-$1K	–	917
2021 Q1	$1K	Buy	+100	New	+$922	﹤0.01%	1973

Other funds holding EOLS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return

Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

SCM

Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

AWH Capital Dallas, Texas $110M AUM 44.24% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Wealthcare Advisory Partners's EOLS Position: Q2 2021 in Review

Wealthcare Advisory Partners sold out of Evolus (EOLS) in Q2 2021, closing a stake of 100 shares — an estimated $1K sold.

Wealthcare Advisory Partners first reported a position in EOLS in Q1 2021 and held it in 1 quarter. The position peaked at $1K in Q1 2021. 115 funds tracked by Wall St. Rank hold EOLS as of Q2 2021.

Wealthcare Advisory Partners reported no remaining Evolus position as of Q2 2021 after selling out during the quarter.
Wealthcare Advisory Partners sold 100 Evolus shares in Q2 2021, an estimated $1K.
Wealthcare Advisory Partners first reported a position in Evolus in Q1 2021 and held it in 1 quarter.
Wealthcare Advisory Partners's Evolus position peaked at $1K in Q1 2021.
115 funds tracked by Wall St. Rank held Evolus as of Q2 2021.

Based on Wealthcare Advisory Partners's 13F filing for Q2 2021, filed 16 Aug 2021.